Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move (TSXV: $FAF.V) (NASDAQ: $NEPT) (TSXV: $BEER.V) (CSE: $CURA.C)(TSX: $AVCN.TO)
Delta, Kelowna, BC –July 24, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/07241FAF-NEPT-BEER-CURA-AVCN.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few early announcements.
Fire & Flower Holdings Corp. (TSXV: FAF), today announced that it has entered into a subscription agreement with respect to a strategic investment by an indirect wholly-owned subsidiary of Alimentation Couche-Tard Inc. (TSX: ATD.A) (TSX: ATD.B). The Company is also pleased to announce that it has received conditional approval to post its common shares for trading on the Toronto Stock Exchange.
The Subscription Agreement allows for Couche-Tard to obtain a controlling interest in the Company with an aggregate investment of more than $380,000,000 of growth capital for Fire & Flower's global expansion.
Fire & Flower has demonstrated that it is capable of rapidly scaling its retail platform through a best-of-class store concept, a leading digital platform and a focus on the safe, responsible and lawful sale of cannabis. This investment will provide Fire & Flower with additional funds to support the further development of its proprietary Hifyre™ digital retail platform and expansion of its retail store network across Canada and internationally where legally permitted.
Concurrent with the closing of the Transaction, the Company will uplist to the TSX.
"This strategic investment by Couche-Tard, one of the world's largest retailers, is transformative for Fire & Flower. The retail cannabis platform we developed marries a best-in-class in-store experience with our proprietary Hifyre™ digital infrastructure and this is a huge vote of confidence in the platform," shared Trevor Fencott, Fire & Flower's Chief Executive Officer. "The support of Couche-Tard's world-class leadership team, coupled with their impressive international footprint which includes major markets such as the US, Mexico and Europe, provide us with outstanding opportunities for aggressive growth."
"Couche-Tard is excited to make this strategic investment in one of the fastest growing cannabis 'pure-play' retailers," said Brian Hannasch, President and CEO of Couche-Tard. "This investment in Fire & Flower, with a path to a controlling stake, will enable us to leverage their leadership, network and advanced digital platform to accelerate our journey in this new and flourishing sector."
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT), a North American leader in extraction, formulation and turnkey packaging solutions, has completed the acquisition of the assets of SugarLeaf Labs, LLC and Forest Remedies LLC. The acquisition was first announced on May 9, 2019.
"The acquisition of SugarLeaf, combined with Neptune allows us to create a leading North American extraction platform with significant capacity available to serve our customers on both sides of the border. Furthermore, considering the significant growth anticipated in hemp-based products, this acquisition provides Neptune with capabilities to satisfy a wide array of clients. Finally, we anticipate a significant contribution from this acquisition, as indicated by the large earnout structure providing adequate risk sharing," said Michael Cammarata, Neptune President and CEO.
Hill Street Beverage Company Inc. (TSXV: BEER) and Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) today announced a multi-faceted expansion of their relationship .
Hill Street and Lexaria have entered into a Joint Manufacturing Partnership valid for 10 years to produce DehydraTECH™ commercial products under a new brand to be announced, including both processed THC and CBD powders in the form of compressed tablets, capsules, or sachets for new consumer products for sale in Canada and for export where permitted, subject to Health Canada approval. These new products could allow consumers to infuse any beverage with cannabis without affecting the taste, smell, or other physical attributes. The JMP will also produce similar powders for use as an ingredient for licensed producers in Canada seeking to use Lexaria's advanced infusion technologies in beverages, edibles and topicals.
Manufacturing will be done at Hill Street's recently announced OneLeaf Cannabis cultivation and processing facility in Regina, Saskatchewan, subject to closing of the OneLeaf acquisition, and its licensing by Health Canada. Hill Street will own and manage all aspects of the manufacturing business under Lexaria's own license and patents for DehydraTECH and its related processes. Profits from this business unit will be shared equally between Hill Street and Lexaria.
Both companies anticipate greatly enhanced cashflows from the JMP, and for Lexaria in particular, the JMP marks its first opportunity to more directly benefit from the emerging federally legal cannabis edibles industry in Canada.
The new JMP between Hill Street and Lexaria will, for the first time ever, permit intermediate ingredients made from cannabis processed by Lexaria's DehydraTECH to be legally sold within Canada on a B2B basis between LP's and others licensed by Health Canada to manufacture cannabis-infused edibles, including both THC and CBD. Cannabis and hemp powders produced using DehydraTECH are extremely stable with two to three-year shelf life, are odorless and tasteless, and yet deliver full spectrum experiences for consumers without having to compromise with isolates and distillates of cannabis oil.
In addition to the manufacturing partnership, Hill Street has acquired a global semi-exclusive license (with minor exceptions) to utilize Lexaria's DehydraTECH™ THC beverage infusion technology and a global non-exclusive license to utilize Lexaria's DehydraTECHTM CBD beverage infusion technology around the world valid for 10 years. This expands the July 31, 2018 license award to Hill Street to use DehydraTECH for THC beverage formulation in Canada only, and positions Hill Street as the only company in the world to have earned a license to use DehydraTECH globally. License royalties for the use of DehydraTECH will be activated as Hill Street enters national markets that have legally allowed the sale of products using Lexaria's technologies.
Hill Street's Chairman & CEO, Terry Donnelly, declared, "When we first began our relationship with Lexaria it was based on a comprehensive competitive review of the market with a single uncompromising vision: to find a technology partner who could provide water soluble cannabis, with zero impact on the award-winning taste and aroma of our products. Lexaria has proven themselves time and again to be the ideal infusion platform for our products, to be committed to continuous improvement and innovation, and to deliver the best consumer experience. This partnership takes our relationship to a whole new level, which we believe will help to set a global standard for excellence that consumers are looking for in cannabis edibles and beverages. Our manufacturing partnership will make this technology available to LP's interested in producing world class edibles, ensuring our industry is able to provide consumers broad-based access to this incredible technology in nearly any product format."
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) announced today the opening of its 25th Florida dispensary at 610 Lake Minnie Drive, as the company continues to expand rapidly throughout the state. Curaleaf has the largest cannabis dispensary footprint in the US, with 48 dispensaries across the country.
"In opening our 3rd Orlando area medical marijuana dispensary, we are proud to be able to provide patients in the communities of Sanford, Lake Mary, Lake Monroe, Longwood, Winter Springs, and Midway, Florida with access to Curaleaf's premium quality products and educational resources," shared Joe Lusardi, Curaleaf CEO.
Curaleaf is commemorating the grand opening of Sanford's first medical marijuana dispensary by providing a sneak-preview to its newest product - Curaleaf Shatter, at the dispensary. Processed using the industry's cleanest, most medically precise extraction and purification methods combined with decades of horticultural experience, Curaleaf Shatter offers patients with qualifying medical conditions a new product option that physicians may consider for their patients. Curaleaf medical cannabis products are also available in the forms of capsules, oils, distillates, concentrates, vaporizer pens, pre-rolls, smokable flower, and topical creams.
Curaleaf's Sanford dispensary will celebrate its grand opening with an event in partnership with the Greater Sanford Regional Chamber of Commerce on Thursday, July 25, 2019. Dispensary operating hours are Monday through Friday, 10am – 7pm; Saturday, 10am – 5pm; and Sunday, Noon – 5pm. Free ample parking is available onsite. The State of Florida's Office of Medical Marijuana Use Registry requires an order from a qualified Florida ordering physician and a State of Florida medical marijuana card to obtain medical marijuana products.
Avicanna Inc. (TSX: AVCN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, announced the commencement of phase I clinical trials on three of its derma-cosmetic products.
Centro de Atención e Investigación Médica CAIMED S.A.S. ("CAIMED") has commenced clinical studies on Avicanna's Pura Earth™ derma-cosmetics products in order to demonstrate their effectiveness with specific cosmetic endpoints, such as reduction of fine lines associated with aging, efficacy as a moisturizer for eczema prone skin, and reduction of sebum and redness attributed to acne. In connection with such clinical studies, CAIMED is currently in the process of recruitment for the Company's intensive conditioner trial for eczema prone skin and expects recruitment for the clear skin and regenerative serum trials to begin in August, with a total of 54 patients expected to be recruited per trial. Once applications have been administered to patients, the trials for clear skin and intensive conditioner are expected to last four weeks with the trial for the regenerative serum expected to last eight weeks. The studies are being completed in Colombia and results are expected to be available prior to commercial launch during the fourth quarter of 2019. Additionally, the Company is unaware of any other trials on https://clinicaltrials.gov involving cannabinoids in Colombia or on derma-cosmetics containing cannabinoids in the world.
"At CAIMED we are very excited and proud of leading the medical cannabis clinical research with Avicanna´s dermatology and cosmetic products. The studies have been designed and are being developed with the highest standards in order to build strong evidence in this new challenging heath care opportunity" said Humberto Reynales, Executive Director of CAIMED.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
